Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer

Hamouda Boussen*, Massimo Cristofanilli, Tal Zaks, Michelle DeSilvio, Vanessa Salazar, Neil Spector

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences